{"id":"https://openalex.org/W4248868233","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.tps257","title":"A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641).","display_name":"A phase III randomized, placebo-controlled, double-blind study of niraparib plus abiraterone acetate and prednisone versus abiraterone acetate and prednisone in patients with metastatic prostate cancer (NCT03748641).","publication_year":2020,"publication_date":"2020-02-19","ids":{"openalex":"https://openalex.org/W4248868233","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.tps257"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.6_suppl.tps257","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.tps257","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.6_suppl.tps257","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005231494","display_name":"Kim N. Chi","orcid":"https://orcid.org/0000-0002-3782-7226","observed_orcids":["https://orcid.org/0000-0002-3782-7226"]},"institutions":[{"id":"https://openalex.org/I4405261103","display_name":"Vancouver Prostate Centre","ror":"https://ror.org/04skhpe58","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4405261103"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Kim N. Chi","raw_affiliation_strings":["BC Cancer and Vancouver Prostate Centre, Vancouver, BC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BC Cancer and Vancouver Prostate Centre, Vancouver, BC, Canada;","institution_ids":["https://openalex.org/I4405261103"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002358672","display_name":"Dana E. Rathkopf","orcid":"https://orcid.org/0000-0002-4503-7582","observed_orcids":["https://orcid.org/0000-0002-4503-7582"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana E. Rathkopf","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000156180","display_name":"Gerhardt Attard","orcid":"https://orcid.org/0000-0002-4811-7983","observed_orcids":["https://orcid.org/0000-0002-4811-7983"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I4210121186","display_name":"Royal Marsden Hospital","ror":"https://ror.org/034vb5t35","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1325846038","https://openalex.org/I4210121186"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gerhardt Attard","raw_affiliation_strings":["Institute of Cancer Research and The Royal Marsden Hospital, Sutton, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer Research and The Royal Marsden Hospital, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I4210121186"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matthew Raymond Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Raymond Smith","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center, Boston, MA;","institution_ids":["https://openalex.org/I4210087915"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078910130","display_name":"Eleni Efstathiou","orcid":"https://orcid.org/0000-0002-3868-1396","observed_orcids":["https://orcid.org/0000-0002-3868-1396"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eleni Efstathiou","raw_affiliation_strings":["Department of Genitourinary Medical Oncology, Division of Cancer Medicine, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Genitourinary Medical Oncology, Division of Cancer Medicine, Houston, TX;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072116005","display_name":"David Olmos","orcid":"https://orcid.org/0000-0002-7003-4826","observed_orcids":["https://orcid.org/0000-0002-7003-4826"]},"institutions":[{"id":"https://openalex.org/I4210089594","display_name":"Spanish National Cancer Research Centre","ror":"https://ror.org/00bvhmc43","country_code":"ES","type":"facility","lineage":["https://openalex.org/I4210089594"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"David Olmos","raw_affiliation_strings":["Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Center, Madrid, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Center, Madrid, Spain;","institution_ids":["https://openalex.org/I4210089594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jay Small","raw_affiliation_strings":["UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA;","institution_ids":["https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063822726","display_name":"Ji Youl Lee","orcid":"https://orcid.org/0000-0001-6775-1157","observed_orcids":["https://orcid.org/0000-0001-6775-1157"]},"institutions":[{"id":"https://openalex.org/I4210160144","display_name":"The Catholic University of Korea Seoul St. Mary's Hospital","ror":"https://ror.org/056cn0e37","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I4210160144","https://openalex.org/I4405260414","https://openalex.org/I87111246"]},{"id":"https://openalex.org/I87111246","display_name":"Catholic University of Korea","ror":"https://ror.org/01fpnj063","country_code":"KR","type":"education","lineage":["https://openalex.org/I87111246"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Ji Youl Lee","raw_affiliation_strings":["Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, South Korea;","institution_ids":["https://openalex.org/I4210160144","https://openalex.org/I87111246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024372930","display_name":"PAUL R. SIEBER","orcid":"https://orcid.org/0000-0002-6064-9683","observed_orcids":["https://orcid.org/0000-0002-6064-9683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul R. Sieber","raw_affiliation_strings":["Lancaster Urology, Lancaster, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lancaster Urology, Lancaster, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018831568","display_name":"Curtis J. Dunshee","orcid":"https://orcid.org/0000-0002-3088-8309","observed_orcids":["https://orcid.org/0000-0002-3088-8309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Curtis Dunshee","raw_affiliation_strings":["Urological Associates of Southern Arizona, Tucson, AZ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Urological Associates of Southern Arizona, Tucson, AZ;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080782271","display_name":"Deborah Sokol Ricci","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Deborah S. Ricci","raw_affiliation_strings":["Janssen Research and Development, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research and Development, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110323335","display_name":"Jason S. Simon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason S. Simon","raw_affiliation_strings":["Bristol-Myers Squibb, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101672157","display_name":"Xin Zhao","orcid":"https://orcid.org/0009-0007-4705-5921","observed_orcids":["https://orcid.org/0009-0007-4705-5921"]},"institutions":[{"id":"https://openalex.org/I4405282460","display_name":"Janssen Research & Development (United States)","ror":"https://ror.org/05wae1a98","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4405282460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin Zhao","raw_affiliation_strings":["Janssen Research & Development, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, San Francisco, CA;","institution_ids":["https://openalex.org/I4405282460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113870041","display_name":"Nishi Kothari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nishi Kothari","raw_affiliation_strings":["Janssen Research & Development, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, Los Angeles, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112509456","display_name":"Shinta Cheng","orcid":"https://orcid.org/0009-0005-4924-6567","observed_orcids":["https://orcid.org/0009-0005-4924-6567"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shinta Cheng","raw_affiliation_strings":["Bristol-Myers Squibb Co, Princeton, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb Co, Princeton, NJ;","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064026461","display_name":"Shahneen Kaur Sandhu","orcid":"https://orcid.org/0000-0002-8660-4475","observed_orcids":["https://orcid.org/0000-0002-8660-4475"]},"institutions":[{"id":"https://openalex.org/I165779595","display_name":"The University of Melbourne","ror":"https://ror.org/01ej9dk98","country_code":"AU","type":"education","lineage":["https://openalex.org/I165779595"]},{"id":"https://openalex.org/I2800555584","display_name":"Peter MacCallum Cancer Centre","ror":"https://ror.org/02a8bt934","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2800555584"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Shahneen Kaur Sandhu","raw_affiliation_strings":["Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Peter MacCallum Cancer Centre, The University of Melbourne, Melbourne, Australia;","institution_ids":["https://openalex.org/I165779595","https://openalex.org/I2800555584"]}]}],"institutions":[],"countries_distinct_count":6,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"6_suppl","first_page":"TPS257","last_page":"TPS257"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.17260000109672546,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/niraparib","display_name":"niraparib","score":0.984000027179718},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/prednisone","display_name":"prednisone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.9869999885559082},{"id":"https://openalex.org/keywords/parp-inhibitors","display_name":"PARP inhibitors","score":0.8830000162124634},{"id":"https://openalex.org/keywords/radiographic-progression-free-survival","display_name":"radiographic progression-free survival","score":0.8980000019073486},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8690000176429749},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5519999861717224},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.7070000171661377},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.6579999923706055},{"id":"https://openalex.org/keywords/safety","display_name":"safety","score":0.3959999978542328}],"concepts":[{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.9540802240371704},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8353933095932007},{"id":"https://openalex.org/C2778720950","wikidata":"https://www.wikidata.org/wiki/Q424972","display_name":"Prednisone","level":2,"score":0.6890622973442078},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6301358342170715},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6186890602111816},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5903009176254272},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.5853182673454285},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5608425140380859},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45954981446266174},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4310702681541443},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.3532048761844635},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31959983706474304},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.20719122886657715},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.17954477667808533},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.6_suppl.tps257","doi":"https://doi.org/10.1200/jco.2020.38.6_suppl.tps257","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.6_suppl.tps257","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337415","display_name":"Janssen Research and Development","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3008112021","https://openalex.org/W2922151518","https://openalex.org/W4212780237","https://openalex.org/W3008866163","https://openalex.org/W2947758134","https://openalex.org/W4281644799","https://openalex.org/W4415941989","https://openalex.org/W3137618571","https://openalex.org/W4225260119","https://openalex.org/W4281770555"],"abstract_inverted_index":{"TPS257":[0],"Background:":[1],"Preclinical":[2],"data":[3],"suggest":[4],"synergistic":[5],"antitumor":[6],"activity":[7],"when":[8],"the":[9,17,90,133,201,233,250,263],"PARP":[10],"inhibitor":[11,20],"(PARPi)":[12],"niraparib":[13,69,95,222],"is":[14,87,203],"combined":[15,72],"with":[16,46,73,77,100,125,221],"androgen":[18,141],"pathway":[19],"abiraterone":[21,30],"acetate.":[22],"(1)":[23],"The":[24,80,150,174,197,276],"addition":[25],"of":[26,49,68,82,94,148,200,232,272,274],"a":[27,60,167,269],"PARPi":[28],"to":[29,88,189,204,241,245,257,282,286],"acetate":[31],"plus":[32,96],"prednisone":[33],"(AAP)":[34],"showed":[35],"improved":[36],"radiographic":[37,206],"progression-free":[38,207],"survival":[39,208],"(rPFS)":[40,209],"vs":[41,235],"AAP":[42,74,97,99,224],"alone":[43],"in":[44,75,115,132,194,249,260,262],"patients":[45,76,124,159,183,219],"mCRPC":[47,126],"regardless":[48],"DNA":[50],"repair":[51],"gene":[52],"defect":[53],"(DRD)":[54],"status.":[55],"(2)":[56],"Interim":[57],"results":[58],"from":[59],"phase":[61],"1":[62],"study":[63,86,112,202],"support":[64],"safety":[65,93],"and":[66,92,121,145,223,227,254,289,293],"tolerability":[67],"200":[70],"mg":[71],"mCRPC.":[78,106],"(3)":[79],"objective":[81,199],"this":[83],"Phase":[84],"3":[85],"compare":[89,205],"efficacy":[91],"versus":[98,225],"placebo":[101,226],"as":[102,164,210],"first-line":[103],"therapy":[104,143],"for":[105,218],"Methods:":[107],"This":[108],"ongoing":[109,140],"multicenter":[110],"MAGNITUDE":[111],"will":[113,122,157,181,296],"open":[114],"300":[116],"sites":[117],"across":[118],"28":[119],"countries":[120],"enroll":[123,182],"who":[127],"have":[128,162,190],"not":[129,187],"received":[130],"treatment":[131],"metastatic":[134],"castrate":[135],"resistant":[136],"setting":[137],"other":[138],"than":[139],"deprivation":[142],"[ADT]":[144],"\u22644":[146],"months":[147],"AAP.":[149,228],"DRD":[151,177,251],"positive":[152,252],"cohort":[153,175,253,264],"(Cohort":[154,178],"1,":[155],"n=400)":[156],"comprise":[158],"whose":[160,184],"tumors":[161,185],"DRD,":[163,266],"determined":[165],"by":[166,212],"previously":[168],"validated":[169],"plasma":[170],"or":[171],"tissue":[172],"assay.":[173],"without":[176,265],"2,":[179],"n=600)":[180],"are":[186,280],"found":[188],"DRD.":[191],"Enrollment":[192],"began":[193],"February":[195],"2019.":[196],"primary":[198],"assessed":[211],"blinded":[213],"independent":[214],"central":[215],"radiology":[216],"review":[217],"treated":[220],"To":[229],"test":[230],"superiority":[231],"combination":[234],"AAP,":[236],"sample":[237],"sizes":[238],"were":[239],"estimated":[240],"provide":[242],"92%":[243],"power":[244,256],"detect":[246,258],"HR\u22640.65":[247],"rPFS":[248,261],"94%":[255],"HR\u22640.67":[259],"both":[267],"at":[268],"2-tailed":[270],"level":[271],"significance":[273],"0.05.":[275],"main":[277],"secondary":[278],"objectives":[279],"time":[281,285],"symptomatic":[283],"progression,":[284],"cytotoxic":[287],"chemotherapy,":[288],"overall":[290],"survival.":[291],"Safety":[292],"pharmacokinetic":[294],"profiles":[295],"be":[297],"evaluated.1)":[298],"Rajendra":[299],"N,":[300,313],"et":[301,314,321],"al.":[302,315,322],"Cancer":[303],"Res":[304],"2019;79":[305],"(13":[306],"Suppl):":[307],"Abstract":[308],"nr":[309],"2134.":[310],"2)":[311],"Clarke":[312],"Lancet":[316],"Oncol.":[317],"2018;(7):975-986.":[318],"3)":[319],"Saad,":[320],"Ann":[323],"Oncol,":[324],"2018;29":[325],"(suppl":[326],"8),":[327],"mdy284.043,":[328],"https://doi.org/10.1093/annonc/mdy284.043":[329],").":[330],"Clinical":[331],"trial":[332],"information:":[333],"NCT03748641.":[334]},"counts_by_year":[{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}